These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2412077)

  • 1. The sulphonylurea receptor may be an ATP-sensitive potassium channel.
    Sturgess NC; Ashford ML; Cook DL; Hales CN
    Lancet; 1985 Aug; 2(8453):474-5. PubMed ID: 2412077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
    Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
    Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mg(2+)-dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells.
    Lee K; Ozanne SE; Hales CN; Ashford ML
    Br J Pharmacol; 1994 Feb; 111(2):632-40. PubMed ID: 8004407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
    Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC
    Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylurea receptors, ion channels, and fruit flies.
    Boyd AE
    Diabetes; 1988 Jul; 37(7):847-50. PubMed ID: 2454858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
    Schwanstecher M; Mnner K; Panten U
    Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
    Anello M; Gilon P; Henquin JC
    Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location of the sulphonylurea receptor at the cytoplasmic face of the beta-cell membrane.
    Schwanstecher M; Schwanstecher C; Dickel C; Chudziak F; Moshiri A; Panten U
    Br J Pharmacol; 1994 Nov; 113(3):903-11. PubMed ID: 7858884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
    Gros L; Virsolvy A; Salazar G; Bataille D; Blache P
    Biochem Biophys Res Commun; 1999 Apr; 257(3):766-70. PubMed ID: 10208857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y; Anello M; Henquin JC
    Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
    Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide.
    Ball AJ; Flatt PR; McClenaghan NH
    Eur J Pharmacol; 2000 Nov; 408(3):327-33. PubMed ID: 11090651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenine nucleotide-induced inhibition of binding of sulphonylureas to their receptor in pancreatic islets.
    Schwanstecher M; Löser S; Brandt C; Scheffer K; Rosenberger F; Panten U
    Br J Pharmacol; 1992 Mar; 105(3):531-4. PubMed ID: 1628141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets.
    Hellman B; Sehlin J; Täljedal IB
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):385-90. PubMed ID: 6230850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
    Lee K; Ozanne SE; Rowe IC; Hales CN; Ashford ML
    Mol Pharmacol; 1994 Jul; 46(1):176-85. PubMed ID: 8058051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular localization and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells.
    Ozanne SE; Guest PC; Hutton JC; Hales CN
    Diabetologia; 1995 Mar; 38(3):277-82. PubMed ID: 7758873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of diazoxide, tolbutamide and ATP4- on nucleotide-dependent K+ channels in an insulin-secreting cell line.
    Dunne MJ; Illot MC; Peterson OH
    J Membr Biol; 1987; 99(3):215-24. PubMed ID: 2447283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the sulfonylurea receptor on beta cell membranes.
    Gaines KL; Hamilton S; Boyd AE
    J Biol Chem; 1988 Feb; 263(6):2589-92. PubMed ID: 3125168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-sensitive K+ channels in human isolated pancreatic B-cells.
    Ashcroft FM; Kakei M; Kelly RP; Sutton R
    FEBS Lett; 1987 May; 215(1):9-12. PubMed ID: 2436949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of tolbutamide and cytosolic nucleotides in controlling the ATP-sensitive K+ channel in mouse beta-cells.
    Schwanstecher C; Dickel C; Panten U
    Br J Pharmacol; 1994 Jan; 111(1):302-10. PubMed ID: 8012711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.